Concepedia

Author

Benjamin Miller

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

B Miller, B. Miller, Benjamin Miller, Benjamin W Miller, Benjamin W. Miller, Miller, Benjamin

31

Publications

1.3K

Citations

11

H-Index

21

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Cubist Pharmaceuticals (United States)University of Cincinnati Medical Center
BM

About

Benjamin Miller is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug resistance, drug discovery, and clinical pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

266

2

Pharmacology

2

2

266

3

Antibiotics

2

2

266

4

Antimicrobial Pharmacodynamics

2

2

266

5

Engineering

1

1

106

Benjamin Miller

×

10

Publications

1.1K

Citations

10

H-Index

YearCitations

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

Joseph S. Solomkin, Ellie Hershberger, Benjamin Miller,

Clinical Infectious Diseases

2015

400

Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic‐derived dose justification for phase 3 studies in patients with nosocomial pneumonia

Alan Xiao, Benjamin Miller, Jennifer A. Huntington,

The Journal of Clinical Pharmacology

2015

149

Pharmacokinetics and Safety of Intravenous Ceftolozane-Tazobactam in Healthy Adult Subjects following Single and Multiple Ascending Doses

Benjamin Miller, Ellie Hershberger, David P. Benziger,

Antimicrobial Agents and Chemotherapy

2012

117

Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> : a pooled analysis of Phase 3 clinical trials

Myra W. Popejoy, David L. Paterson, Daniel Cloutier,

Journal of Antimicrobial Chemotherapy

2016

115

Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult Patients with Complicated Intra-Abdominal Infections

Christopher Lucasti, Ellie Hershberger, Benjamin Miller,

Antimicrobial Agents and Chemotherapy

2014

107

Prairie Night: Black-Footed Ferrets and the Recovery of Endangered Species

Hilary O. Box, Benjamin Miller, R. P. Reading,

Journal of Wildlife Management

1998

106

Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-Tazobactam

Myra Wooley, Benjamin Miller, Gopal Krishna,

Antimicrobial Agents and Chemotherapy

2014

72

Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study

Benjamin Miller, Myra W. Popejoy, Ellie Hershberger,

Antimicrobial Agents and Chemotherapy

2016

35

Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

Teresa L. Kauf, Vimalanand S. Prabhu, Goran Medić,

BMC Infectious Diseases

2017

15

Pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Japanese, Chinese, and white subjects

Anthony Aiudi, Benjamin Miller, Gopal Krishna,

Fundamental and Clinical Pharmacology

2016

14

Page 1